Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1674
    +0.0018 (+0.15%)
     

  • GBP/USD

    1.2478
    -0.0033 (-0.26%)
     

  • Bitcoin GBP

    50,868.61
    -445.05 (-0.87%)
     

  • CMC Crypto 200

    1,322.08
    -74.45 (-5.33%)
     

  • S&P 500

    5,102.47
    +54.05 (+1.07%)
     

  • DOW

    38,255.10
    +169.30 (+0.44%)
     

  • CRUDE OIL

    84.03
    +0.46 (+0.55%)
     

  • GOLD FUTURES

    2,347.00
    +4.50 (+0.19%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

New Strong Sell Stocks for June 7th

Zacks Equity Research
·1-min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

CONMED Corporation CNMD is a medical technology company that sells surgical devices. The Zacks Consensus Estimate for its current year earnings has been revised 5.1% downward over the last 60 days.

Colgate-Palmolive Company CL is a global consumer products company. The Zacks Consensus Estimate for its current year earnings has been revised nearly 7% downward over the last 60 days.

Colony Bankcorp, Inc. CBAN is the bank holding company for Colony Bank. The Zacks Consensus Estimate for its current year earnings has been revised 10.6% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CONMED Corporation (CNMD) : Free Stock Analysis Report
 
ColgatePalmolive Company (CL) : Free Stock Analysis Report
 
Colony Bankcorp, Inc. (CBAN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research